Certara, a US-based healthcare company, and ChemAxon, a provider of cheminformatics software platforms and desktop applications for the biotechnology and pharmaceutical industries, have signed a partnership agreement.
The partnership will focus on offering seamless access to ChemAxon's MarvinSketch and JChem Cartridge for Oracle via Certara's D360.
D360 is an integrated solution for query, analysis and visualization of scientific data.
It is used by pharmaceutical and biotech companies to offer unified access to disparate data sources throughout drug discovery and development, which helps to improve research productivity.
Certara Scientific Informatics vice president Jonathan Feldmann said, "Part of the value of D360 is being able to easily connect to an organization's existing infrastructure, and we are increasingly finding that ChemAxon is part of the core chemistry infrastructure.
"We are now able to seamlessly integrate and deliver other data types, such as biologic assay or preclinical safety data with chemistry data from ChemAxon via simple queries that any user can develop."
ChemAxon CEO Alex Drijver said that the company is happy to have Certara join the expanding list of major application providers integrating its platform within their solutions.
"This gives customers tremendous flexibility to have what best suits their needs being provided by an established partner group," Drijver added.
